A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
Clinical trial NCT05125016 · RECRUITING
Trial details
- NCT number
- NCT05125016
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2030-03-28
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.